Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Cash Flow Statement

Financials in millions CNY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023
Net Income	-12.83	-1.28	-0.99
Depreciation & Amortization	0.01	0.01	0.03
Other Adjustments	8.17	0.49	0.41
Change in Receivables	14.17	6.53	9.88
Changes in Inventories	-0.31	3.06	1.44
Changes in Accounts Payable	-5.64	5.78	-8.76
Changes in Accrued Expenses	-0.32	-0.25	-0.93
Changes in Income Taxes Payable	-0.33	0.33	-1.08
Changes in Unearned Revenue	-1.6	1.14	0.26
Changes in Other Operating Activities	-7.73	-1.17	-6.33
Operating Cash Flow	-6.43	14.63	-6.08
Other Investing Activities	-	15	-3.37
Investing Cash Flow	-	15	-3.37
Short-Term Debt Issued	10	15.6	42.5
Short-Term Debt Repaid	-10	-48.1	-35.5
Net Short-Term Debt Issued (Repaid)	-	-32.5	7
Issuance of Common Stock	108.19	-	-
Net Common Stock Issued (Repurchased)	108.19	-	-
Common Dividends Paid	-	-0.32	-9.6
Other Financing Activities	-64.53	2.73	11.48
Financing Cash Flow	43.66	-30.09	8.87
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.67	-0	0
Net Cash Flow	37.23	-0.46	-0.58
Free Cash Flow	-6.43	14.63	-6.08
FCF Margin	-18.82%	16.70%	-7.37%
Free Cash Flow Per Share	-0.35	0.81	-0.34
Levered Free Cash Flow	-28.76	-24.89	-9.37
Unlevered Free Cash Flow	-28.78	8.89	-29.97

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.